Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$160,000.00
Agreement Date:
Apr 1, 2014 - Mar 31, 2015
Description:
Benchmark proprietary pyridine- and thienopyrimidine-based bisphosphonates against the standard of care drug Zometa® in the treatment of multiple myeloma
Organization:
Canadian Institutes of Health Research
Location:
Montreal, Quebec, CA H3A 2T5
Reference Number:
236-2013-2014-Q4-00463
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient's Legal Name:
TSANTRIZOS, Youla S
Research Organization:
McGill University|Université McGill